The Impact of Cell Density and Mutations in a Model of Multidrug Resistance in Solid Tumors
暂无分享,去创建一个
[1] Laird Ak. DYNAMICS OF TUMOR GROWTH. , 1964 .
[2] A. K. Laird. Dynamics of Tumour Growth , 1964, British Journal of Cancer.
[3] L. Norton,et al. Tumor size, sensitivity to therapy, and design of treatment schedules. , 1977, Cancer treatment reports.
[4] L. Norton,et al. Growth curve of an experimental solid tumor following radiotherapy. , 1977, Journal of the National Cancer Institute.
[5] Goldie Jh,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .
[6] J H Goldie,et al. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979, Cancer treatment reports.
[7] Goldie Jh,et al. Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982 .
[8] J H Goldie,et al. Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.
[9] J. Goldie,et al. Quantitative model for multiple levels of drug resistance in clinical tumors. , 1983, Cancer treatment reports.
[10] J. Goldie,et al. A model for the resistance of tumor cells to cancer chemotherapeutic agents , 1983 .
[11] Goldie Jh,et al. Role of mathematical modeling in protocol formulation in cancer chemotherapy. , 1985 .
[12] L Corcoran,et al. Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c‐myc oncogene. , 1985, The EMBO journal.
[13] L. Norton,et al. The Norton-Simon hypothesis revisited. , 1986, Cancer treatment reports.
[14] J H Goldie,et al. A stochastic model for the origin and treatment of tumors containing drug-resistant cells. , 1986, Bulletin of mathematical biology.
[15] R Rosen,et al. "Role of mathematical modeling in protocol formulation in cancer chemotherapy". , 1986, Cancer treatment reports.
[16] S Gallivan,et al. A mathematical model of the development of drug resistance to cancer chemotherapy. , 1987, European journal of cancer & clinical oncology.
[17] M Kimmel,et al. Mathematical models of gene amplification with applications to cellular drug resistance and tumorigenicity. , 1990, Genetics.
[18] Z. Agur,et al. The dynamics of gene amplification described as a multitype compartmental model and as a branching process. , 1991, Mathematical biosciences.
[19] S. Michelson,et al. A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance. , 1992, Bulletin of mathematical biology.
[20] O. Bogler,et al. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. , 1996, Cancer research.
[21] K. Miyazono,et al. Cell Density-dependent Apoptosis in HL-60 Cells, Which Is Mediated by an Unknown Soluble Factor, Is Inhibited By Transforming Growth Factor β1 and Overexpression of Bcl-2* , 1997, The Journal of Biological Chemistry.
[22] Nicola Bellomo,et al. Nonlinear models and problems in applied sciences from differential quadrature to generalized collocation methods , 1997 .
[23] J. Panetta,et al. A mathematical model of drug resistance: heterogeneous tumors. , 1998, Mathematical biosciences.
[24] G. Farrell,et al. The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture , 1999, In Vitro Cellular & Developmental Biology - Animal.
[25] G. Webb,et al. Mutation, selection, and recombination in a model of phenotype evolution , 1999 .
[26] H M Byrne,et al. A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy. , 2000, Mathematical biosciences.
[27] À. Calsina,et al. A model for the adaptive dynamics of the maturation age , 2000 .
[28] Sophie Lelièvre,et al. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.
[29] Urszula Foryś,et al. Logistic Equations in Tumour Growth Modelling , 2003 .
[30] Baofeng Yang,et al. Opposite Cell Density-Dependence between Spontaneous and Oxidative Stress-Induced Apoptosis in Mouse Fibroblast L-Cells , 2003, Cellular Physiology and Biochemistry.
[31] John Carl Panetta,et al. Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies , 2003, SIAM J. Appl. Math..
[32] Sílvia Cuadrado,et al. Small mutation rate and evolutionarily stable strategies in infinite dimensional adaptive dynamics , 2004, Journal of mathematical biology.
[33] Nastaran Zahir,et al. Death in the third dimension: apoptosis regulation and tissue architecture. , 2004, Current opinion in genetics & development.
[34] Urszula Ledzewicz,et al. Drug resistance in cancer chemotherapy as an optimal control problem , 2005 .
[35] Dominik Wodarz,et al. Drug resistance in cancer: principles of emergence and prevention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Perthame,et al. The dynamics of adaptation: an illuminating example and a Hamilton-Jacobi approach. , 2005, Theoretical population biology.
[37] N. Komarova,et al. Stochastic modeling of drug resistance in cancer. , 2006, Journal of theoretical biology.
[38] I. Tannock,et al. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.
[39] B. Perthame. Transport Equations in Biology , 2006 .
[40] R. Ferrière,et al. Unifying evolutionary dynamics: from individual stochastic processes to macroscopic models. , 2006, Theoretical population biology.
[41] L. Sander,et al. Dynamics and pattern formation in invasive tumor growth. , 2005, Physical review letters.
[42] G. Barles,et al. Dirac concentrations in Lotka-Volterra parabolic PDEs , 2007, 0708.3720.
[43] Michael Berens,et al. A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment. , 2007, Biophysical journal.
[44] S. Mischler,et al. On selection dynamics for continuous structured populations , 2008 .
[45] Christopher P Austin,et al. A dual-fluorescence high-throughput cell line system for probing multidrug resistance. , 2009, Assay and drug development technologies.
[46] Jean-Pierre Gillet,et al. Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.
[47] D. Levy,et al. An elementary approach to modeling drug resistance in cancer. , 2010, Mathematical biosciences and engineering : MBE.
[48] B. Perthame,et al. Dirac Mass Dynamics in Multidimensional Nonlocal Parabolic Equations , 2010, 1011.1768.
[49] L. Liotta,et al. Mechanism of Cell Adaptation: When and How Do Cancer Cells Develop Chemoresistance? , 2011, Cancer journal.
[50] B. Perthame,et al. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies , 2012, 1207.0923.
[51] Doron Levy,et al. The dynamics of drug resistance: a mathematical perspective. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[52] Martin A Nowak,et al. Dynamics of targeted cancer therapy. , 2012, Trends in molecular medicine.
[53] R. Minchin,et al. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives , 2012, EMBO molecular medicine.
[54] M. Textor,et al. Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses , 2012, PloS one.
[55] Kornelia Polyak,et al. Cancer Cell Phenotypes, in Fifty Shades of Grey , 2013, Science.
[56] M. Gottesman,et al. The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance , 2013 .
[57] Andrew M. K. Brown,et al. Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.
[58] Doron Levy,et al. Simplifying the complexity of resistance heterogeneity in metastasis. , 2014, Trends in molecular medicine.
[59] Kornelia Polyak,et al. Cancer Cell Phenotypes, in Fifty Shades of Grey , 2013, Science.